Contact-tracing tech advances, the new saliva test, and more COVID-19 updates

A roundup of the top stories you may have missed this week.

The coronavirus crisis is unique. Addressing it will require new ideas, new perspectives, and new voices. That’s our mission at Freethink.

In our weekly “Coronavirus News Roundup,” we’re highlighting the most important stories from the frontlines of the fight against COVID-19. Stories that inform, challenge, and inspire.

Here are our must reads for today, April 17, 2020.

1. The FDA Approves the First Saliva Test for the Coronavirus

If you need to get tested for the coronavirus in the future, you might not have to endure an unpleasant deep nose swab as the Food and Drug Administration has given a new saliva-based test the green light.

2. Apple and Google Join Forces on a Coronavirus Tracking Project

Two of the world’s biggest tech companies have teamed up to tackle a major problem for health researchers: effectively tracking the coronavirus’s spread without infringing upon people’s right to privacy.

3. Doctors Use AI to Test New Coronavirus Treatments on Patients

The AI platform at the center of a newly launched clinical trial is helping researchers quickly identify the coronavirus treatments that are helping patients — and quickly abandon those that aren’t.

4. Major League Baseball Joins a Massive Coronavirus Antibody Study

More than 10,000 players and employees from the MLB agreed to have their blood tested for coronavirus antibodies in a massive study that could help bring an end to COVID-19 lockdowns.

5. Across America, Libraries Are Fighting the Coronavirus

With their doors currently closed to the public, libraries across the U.S. have pivoted their attention toward the COVID-19 pandemic — and they’re making a difference in some incredible ways.

Related
The (robotic) doctor will see you now
Study finds patients are receptive to interacting with robots designed to evaluate symptoms in a contact-free way.
New brain cancer vaccine completes clinical trial
Northwest Biotherapeutics reports that its new brain cancer vaccine can extend glioblastoma patients’ lives by months or even years.
New chemo pump for brain tumors could avoid side effects
A fully implantable chemo pump could help extend the lives of people with deadly brain tumors while minimizing treatment side effects.
UK study suggests single dose of monkeypox vaccine is 78% effective
A new analysis by the UK Health Security Agency has determined that one shot of a monkeypox vaccine is 78% effective at preventing infection.
$3.5 million treatment for hemophilia wins FDA approval
The FDA has approved biotech company CSL Behring’s Hemgenix, a hemophilia B treatment that costs $3.5 million per dose.
Up Next
Coronavirus Antibody Tests
Subscribe to Freethink for more great stories